Lear SA, Humphries KH, Kohli S, Frohlich JJ, Birmingham CL, Mancini GB: Visceral adipose tissue, a potential risk factor for carotid atherosclerosis: results of the Multicultural Community Health Assessment Trial (M-CHAT). Stroke. 2007, 38 (9): 2422-2429. 10.1161/STROKEAHA.107.484113.
Article
PubMed
Google Scholar
Ditomasso D, Carnethon MR, Wright CM, Allison MA: The associations between visceral fat and calcified atherosclerosis are stronger in women than men. Atherosclerosis. 2010, 208 (2): 531-536. 10.1016/j.atherosclerosis.2009.08.015.
Article
CAS
PubMed
Google Scholar
Cascella T, Palomba S, De Sio I, Manguso F, Giallauria F, De Simone B, Tafuri D, Lombardi G, Colao A, Orio F: Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod. 2008, 23 (1): 153-159.
Article
CAS
PubMed
Google Scholar
Konishi K, Nakano S, Seto H, Tsuda S, Koya D: Carotid atherosclerosis mediated by visceral adiposity and adipocytokines in type 2 diabetic subjects. Diabetes Res Clin Pract. 2009, 85 (2): 171-178. 10.1016/j.diabres.2009.04.021.
Article
CAS
PubMed
Google Scholar
Kishida K, Funahashi T, Matsuzawa Y, Shimomura I: Visceral adiposity as a target for the management of the metabolic syndrome. Ann Med. 2012, 44 (3): 233-241. 10.3109/07853890.2011.564202.
Article
CAS
PubMed
Google Scholar
Mafra D, Guebre-Egziabher F, Fouque D: Body mass index, muscle and fat in chronic kidney disease: questions about survival. Nephrol Dial Transplant. 2008, 23 (8): 2461-2466. 10.1093/ndt/gfn053.
Article
CAS
PubMed
Google Scholar
Huang JW, Lien YC, Wu HY, Yen CJ, Pan CC, Hung TW, Su CT, Chiang CK, Cheng HT, Hung KY: Lean body mass predicts long-term survival in Chinese patients on peritoneal dialysis. PLoS One. 2013, 8 (1): e54976-10.1371/journal.pone.0054976.
Article
PubMed Central
CAS
PubMed
Google Scholar
Odamaki M, Furuya R, Ohkawa S, Yoneyama T, Nishikino M, Hishida A, Kumagai H: Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial Transplant. 1999, 14 (10): 2427-2432. 10.1093/ndt/14.10.2427.
Article
CAS
PubMed
Google Scholar
Kato A, Ishida J, Endo Y, Takita T, Furuhashi M, Maruyama Y, Odamaki M: Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients. Nephrol Dial Transplant. 2011, 26 (6): 1967-1976. 10.1093/ndt/gfq652.
Article
PubMed
Google Scholar
Miyamoto T, Rashid Qureshi A, Heimburger O, Barany P, Carrero K, Sjoberg B, Lindholm B, Stenvinkel P, Carrero JJ: Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease. Clin J Am Soc Nephrol. 2011, 6 (12): 2785-2791. 10.2215/CJN.02320311.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lee MJ, Shin DH, Kim SJ, Oh HJ, Yoo DE, Kim JK, Park JT, Han SH, Kang SW, Choi KH: Visceral fat thickness is associated with carotid atherosclerosis in peritoneal dialysis patients. Obesity (Silver Spring). 2012, 20 (6): 1301-1307. 10.1038/oby.2011.245.
Article
CAS
Google Scholar
Wu HY, Hung KY, Huang TM, Hu FC, Peng YS, Huang JW, Lin SL, Chen YM, Chu TS, Tsai TJ: Safety issues of long-term glucose load in patients on peritoneal dialysis--a 7-year cohort study. PLoS One. 2012, 7 (1): e30337-10.1371/journal.pone.0030337.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wu HY, Hung KY, Huang JW, Chen YM, Tsai TJ, Wu KD: Initial glucose load predicts technique survival in patients on chronic peritoneal dialysis. Am J Nephrol. 2008, 28 (5): 765-771. 10.1159/000128608.
Article
CAS
PubMed
Google Scholar
Wu HY, Hung KY, Hu FC, Chen YM, Chu TS, Huang JW, Wu KD, Tsai TJ: Risk factors for high dialysate glucose use in PD patients--a retrospective 5-year cohort study. Perit Dial Int. 2010, 30 (4): 448-455. 10.3747/pdi.2009.00063.
Article
CAS
PubMed
Google Scholar
Cheng SC, Chu TS, Huang KY, Chen YM, Chang WK, Tsai TJ, Wu KD: Association of hypertriglyceridemia and insulin resistance in uremic patients undergoing CAPD. Perit Dial Int. 2001, 21 (3): 282-289.
CAS
PubMed
Google Scholar
Chen HY, Kao TW, Huang JW, Chu TS, Wu KD: Correlation of metabolic syndrome with residual renal function, solute transport rate and peritoneal solute clearance in chronic peritoneal dialysis patients. Blood Purif. 2008, 26 (2): 138-144. 10.1159/000113506.
Article
CAS
PubMed
Google Scholar
Li PK, Kwan BC, Ko GT, Chow KM, Leung CB, Szeto CC: Treatment of metabolic syndrome in peritoneal dialysis patients. Perit Dial Int. 2009, 29 (Suppl 2): S149-S152.
CAS
PubMed
Google Scholar
Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD: Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis. 2004, 43 (6): 1047-1055. 10.1053/j.ajkd.2004.02.017.
Article
PubMed
Google Scholar
Chujo D, Yagi K, Asano A, Muramoto H, Sakai S, Ohnishi A, Shintaku-Kubota M, Mabuchi H, Yamagishi M, Kobayashi J: Telmisartan treatment decreases visceral fat accumulation and improves serum levels of adiponectin and vascular inflammation markers in Japanese hypertensive patients. Hypertens Res. 2007, 30 (12): 1205-1210. 10.1291/hypres.30.1205.
Article
CAS
PubMed
Google Scholar
Nakagawa N, Yao N, Hirayama T, Ishida M, Ishida H, Wada A, Fujino T, Saijo Y, Kikuchi K, Hasebe N: Potential impact of renin-angiotensin system inhibitors and calcium channel blockers on plasma high-molecular-weight adiponectin levels in hemodialysis patients. Hypertens Res. 2011, 34 (5): 592-598. 10.1038/hr.2010.282.
Article
CAS
PubMed
Google Scholar
Deedwania P: Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating beta-blockers. J Clin Hypertens (Greenwich). 2011, 13 (1): 52-59. 10.1111/j.1751-7176.2010.00386.x.
Article
CAS
Google Scholar
Chan DC, Watts GF: Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies. Expert Opin Pharmacother. 2011, 12 (1): 13-30. 10.1517/14656566.2010.502529.
Article
CAS
PubMed
Google Scholar
Gotoh H, Gohda T, Tanimoto M, Gotoh Y, Horikoshi S, Tomino Y: Contribution of subcutaneous fat accumulation to insulin resistance and atherosclerosis in haemodialysis patients. Nephrol Dial Transplant. 2009, 24 (11): 3474-3480. 10.1093/ndt/gfp290.
Article
CAS
PubMed
Google Scholar
Dobiasova M, Frohlich J: The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001, 34 (7): 583-588. 10.1016/S0009-9120(01)00263-6.
Article
CAS
PubMed
Google Scholar
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002, 106 (25): 3143-3421.
Google Scholar
Lin CC, Chen CC, Kung PT, Li CI, Yang SY, Liu CS, Lin WY, Lee CC, Li TC, Kardia SL: Joint relationship between renal function and proteinuria on mortality of patients with type 2 diabetes: the taichung diabetes study. Cardiovasc Diabetol. 2012, 11: 131-10.1186/1475-2840-11-131.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kim CS, Choi JS, Park JW, Bae EH, Ma SK, Jeong MH, Kim YJ, Cho MC, Kim CJ, Kim SW: Concomitant renal insufficiency and diabetes mellitus as prognostic factors for acute myocardial infarction. Cardiovasc Diabetol. 2011, 10: 95-10.1186/1475-2840-10-95.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bhardwaj S, Misra A, Misra R, Goel K, Bhatt SP, Rastogi K, Vikram NK, Gulati S: High prevalence of abdominal, intra-abdominal and subcutaneous adiposity and clustering of risk factors among urban Asian Indians in North India. PLoS One. 2011, 6 (9): e24362-10.1371/journal.pone.0024362.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bazanelli AP, Kamimura MA, Manfredi SR, Draibe SA, Cuppari L: Usefulness of waist circumference as a marker of abdominal adiposity in peritoneal dialysis: a cross-sectional and prospective analysis. Nephrol dialy trans off publ European Dialy Trans Assoc European Renal Assoc. 2012, 27 (2): 790-795.
Google Scholar
Ruan X, Guan Y: Metabolic syndrome and chronic kidney disease. J Diabetes. 2009, 1 (4): 236-245. 10.1111/j.1753-0407.2009.00042.x.
Article
CAS
PubMed
Google Scholar
Guzik TJ, Mangalat D, Korbut R: Adipocytokines - novel link between inflammation and vascular function?. J Physiol Pharmacol. 2006, 57 (4): 505-528.
CAS
PubMed
Google Scholar
Kaysen GA: The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol. 2001, 12 (7): 1549-1557.
CAS
PubMed
Google Scholar
Cordeiro AC, Qureshi AR, Stenvinkel P, Heimburger O, Axelsson J, Barany P, Lindholm B, Carrero JJ: Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. Nephrol Dial Transplant. 2010, 25 (2): 562-568. 10.1093/ndt/gfp492.
Article
PubMed
Google Scholar
Lu Q, Cheng LT, Wang T, Wan J, Liao LL, Zeng J, Qin C, Li KJ: Visceral fat, arterial stiffness, and endothelial function in peritoneal dialysis patients. J renal nutri off j Council Renal Nutri Nat Kidney Found. 2008, 18 (6): 495-502. 10.1053/j.jrn.2008.05.006.
Article
Google Scholar
Wu CK, Huang YT, Lin HH, Yang CY, Lien YC, Lee JK, Huang JW, Hung KY: Dissecting the mechanisms of left ventricular diastolic dysfunction and inflammation in peritoneal dialysis patients. PLoS One. 2013, 8 (5): e62722-10.1371/journal.pone.0062722.
Article
PubMed Central
CAS
PubMed
Google Scholar
Saiki A, Ohira M, Endo K, Koide N, Oyama T, Murano T, Watanabe H, Miyashita Y, Shirai K: Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus. Metabolism. 2009, 58 (5): 708-713. 10.1016/j.metabol.2009.01.013.
Article
CAS
PubMed
Google Scholar
McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM: Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010, 362 (16): 1477-1490.
Article
CAS
PubMed
Google Scholar
Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Wright JT, Oakes R, Lukas MA: Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA. 2004, 292 (18): 2227-2236. 10.1001/jama.292.18.2227.
Article
CAS
PubMed
Google Scholar
Kovesdy CP, Anderson JE, Kalantar-Zadeh K: Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis. 2007, 49 (5): 581-591. 10.1053/j.ajkd.2007.02.277.
Article
PubMed
Google Scholar
Perl J, Bargman JM: The importance of residual kidney function for patients on dialysis: a critical review. Am J Kidney Dis. 2009, 53 (6): 1068-1081. 10.1053/j.ajkd.2009.02.012.
Article
PubMed
Google Scholar